Coronavirus Flash Update: August 17, 2020

This is the final regular edition of Alston & Bird’s Coronavirus Flash Update, the 47th. With nearly 6,000 subscribers, we are proud of what we were able to achieve; supporting our clients and the public with vital information during extraordinarily challenging times. You are invited to keep in touch with us by subscribing to the firm’s advisories of your choice by clicking here. We hope to stay in touch. 

The Latest News

• U.S. COVID-19 cases exceed 5,374,002 and 168,690 U.S. deaths. (Source: CDC) (Updated 8/17/20)
• U.S. stock market: On Friday the major benchmarks ended with mixed results for the day, with the Dow rising 34 points, while the S&P and Nasdaq lost less than a point and 26 points, respectively. (New)
• With Congressional Coronavirus emergency aid talks stalled, the Senate departed last week for the traditional August recess; the House departed the previous week. Both bodies could return early subject to the call of their respective leadership if behind the scenes negotiations bear any result, but they are otherwise out until September 8. A key area of disagreement is aid to state and local governments which range from the $150 billion offer by the Administration to the roughly $1 trillion proposal by the Democrats. Liability protection for employers is another area of debate as reflected by a comprehensive proposal included in the Senate GOP HEALS Act and no language in the House passed HEROES bill. Absent movement on negotiations it looks like agreement on an emergency relief package will fall to September when Congress must also finalize the fiscal year 2021 spending bills before October 1^st. (New)
• House Speaker Nancy Pelosi has called members back to DC this week to work on US Postal Service aid. The House has stated its plans to move forward on a free-standing bill, but the President last week stated he would support aid if included in the emergency stimulus package currently being be negotiated. (New)
• The Small Business Administration Paycheck Protection Program (PPP) closed to applications on August 8, but the agency has released several relevant updates on PPP loan forgiveness and appeals (8/11/20):
• The SBA released Interim Final Rule - Appeals of SBA PPP Loan Review Decisions (New)
• Added questions 50 & 51 to the PPP FAQs (New)
• FAQs for PPP Loan Forgiveness (New)
• The Department of Labor (DOL) has moved forward on the Presidents Executive Order last week to extend supplemental unemployment benefits. On August 12, the DOL announced guidance for the Lost Wages Assistance Program to provide claimants in most Unemployment Insurance programs up to $400 per week additional benefits starting on or after August 1, 2020 and ending December 27, 2020 at the latest. The funds are provided to a grant from the Federal Emergency Management Administration (FEMA). (New)
• On August 14, the Department of Health and Human Services announced $1.4 billion for a third Safety Net Hospital targeted distribution to certain children’s hospitals. (New)

COVID-19 Federal Legislation   

• Bill 4.0: The Senate $1 trillion HEALS Act proposal announced on July 27 laid out the GOP alternative to the Democratic House passed the HEROES Act in May. Details are both are below:
• The HEALS Act was released on July 27 in sections by the authorizing committees:
  • Senate Finance, S. 4318: Text, Section-by-Section
  • Senate Liability Protections, S. 4317: Text
  • Senate Small Business, S. 4321: Text, Section-by-Section
  • Senate Appropriations Health, Education, and Labor : Section-by-Section
  • Senate Appropriations Supplemental, S. 4320: Text, Section-by-Section
  • Senate Trust Funds, S. 4323: Text, Section-by-Section
  • Senate HELP – Education: Section-by-Section
  • Senate HELP – Education School Choice, S. 4322: Text, Summary
  • Senate Supply Chain, S. 4324: Text
  • Senate Restaurant Workers, S. 4319: Text
• The HEROES Act was the first formal offer on a new emergency stimulus bill, 4.0: For the full details on the HEROES Act, H.R. 6800, which passed the House on May 15:
  • The HEROES Act text is available here.
  • A 1-pager and 71 page section-by-section summary are available here.
  • And an outline of the state and local funding provisions is here.
• The Paycheck Protection Flexibility Act, H.R. 7010, was enacted on June 5. To learn more, see this A&B Summary of the Paycheck Protection Flexibility Act. (6/5/20)
• Bill 3.5: Paycheck Protection Program and Health Care Enhancement Act, (R. 266) was enacted on April 24. Also available are a section-by-section summary and an overview of the health care provisions.
• A&B detailed summaries are below:
  • A&B Summary – 5 Small Business Provisions
  • A&B Summary – 5 Health Care Enhancement Provisions
• Bill 3.0: Coronavirus Aid, Relief, and Economic Security (CARES) Act, (R. 748) passed on March 27. A congressional section by section summary is available here.
• Congress has passed three coronavirus emergency response bills and the first two are below:
• Bill 1.0: Coronavirus Preparedness and Response Supplemental (CPPRS) (R. 6074) passed on March 5
• Bill 2.0: Families First Coronavirus Response Act (FFCRA) (R. 6201) passed on March 18

Transition to “Reopening”   

• Administration Actions
  • A&B’s Cybersecurity Preparedness & Response Team offers six practical tip for practicing cyberhygiene in the middle of a pandemic for businesses. (8/13/20) (New)
  • The CDC updated or released guidance for reopening:
  • Worker Safety and Support (Updated 8/13/20)
  • Employer Information for Gyms and Fitness Centers (Updated 8/13/20)
  • Businesses and Workplaces (Updated 8/11/20)
  • Strategies for K-12 School Administrators on the Use of Cloth Face Coverings in Schools (Updated 8/10/20)
• State/Other Actions
  • For the latest information on state reopening decisions, see A&B 50-State reopening tracker - updated in each A&B Coronavirus Flash. (Updated 8/15/20)

Department of Health and Human Services   

• HHS has a tracking feature that allows public viewing of all COVID-19 HHS grants and cooperative agreement awards on its website. The grants were distributed through programs in the ACF, ACL, ASPR, CDC, DHHS/OS, HRSA, IHS, NIH, and SAMHSA. (Updated 8/13/20)
• The HHS Office of Assistant Secretary of Preparedness and Response (ASPR) updated a table on the allocation and distribution of Remdesivir. (Updated 8/14/20)
• HHS has created a new public data website as a COVID-19 Resource. (Updated 8/16/20)
• HHS published a fact sheet explaining Operation Warp Speed. (Updated 8/12/20)
• HHS announced an investment of $6.5 million in two commercial diagnostic laboratories – Aegis Sciences Corporation and Sonic Healthcare USA – to conduct up to 4 million additional SARS-CoV-2 tests per month. The investment will also provide laboratory equipment supplied by Beckman Coulter Life Sciences and Thermo Fisher Scientific. (8/13/20) (New)
• HHS issued notice of funding opportunity to expand and accelerate the innovative use of electronic health information via health information exchanges to support state and local public health agencies. (8/12/20) (New)
• HHS and the Department of Defense announced:
• agreement with McKesson Corporation to distribute future COVID-19 vaccines (8/14/20) (New)
• agreement with Moderna to manufacture 100 million doses of a Moderna vaccine candidate. (8/11/20) (New)
• agreement with BioFire Defense, LLC to expand the production of DOD testing. (8/10/20) (New)
• The HHS Health Resources and Services Administration (HRSA) has released a dashboard on COVID-19 test including race and ethnicity. (8/10/20) (New)
• HHS posted testing plans July through December for all states, territories and localities. (8/10/20) (New)

• HHS announced $1.4 billion for a third Safety Net Hospital targeted distribution to certain children’s hospitals. (8/14/20) (New)
• HHS, through HRSA, announced Phase 2 General Distribution application process for eligible Medicaid, CHIP, Dental and certain other programs. (8/10/20) (New)
• HHS - the CARES Act Provider Relief Fund (PRF) webpage (Updated 8/14/20)
• And the PRF FAQs (Updated 8/10/20) have been updated and capture numerous modifications.
• PRF high impact round 2 state-by-state breakdown. (8/11/20) (New)
• The CDC has posted an updated dataset of provider recipient specific payment from the Provider Relief Fund general distribution high impact targeted allocation and/or rural targeted allocation. The dataset includes who has attested to receiving one or more payments and agreed to the terms and conditions as of August 13. (Updated 8/13/20)
• A&B Hospital Provisions from all 4 bills tracker (Updated 8/16/20)
• A&B Provider Relief Fund Disbursements tracker (Updated 8/16/20)

Centers for Disease Control and Prevention  

• The Centers for Disease Control and Prevention (CDC) COVIDView Weekly Summary is available. (Updated 8/14/20)
• The CDC weekly COVID forecast. (Updated 8/12/20)
• The CDC S. testing data. (Updated 8/16/20)
• The CDC FAQs on testing for SARS-CoV-2. (Updated 8/14/20)
• CDC updated its FAQs for laboratories. (Updated 8/15/20)
• CDC electronic laboratory reporting map. (Updated 8/13/20)
• CDC interim guidance and guidelines for laboratory biosafety in handling and processing COVID-19 specimens (Updated 8/11/20)
• The CDC has been moving to a more detailed COVID-19 electronic laboratory reporting (CELR) form with state and jurisdictional health departments. (8/13/20) (New)
• The CDC has released guidance for:
• Ending Home Isolation (Updated 8/16/20)
• Social Service Providers for In-Home Care (8/12/20) (New)
• Healthcare Workers in Non-US healthcare settings (8/12/20) (New)
• Returning to Work for Healthcare Personnel Post Infection (8/10/20) (New)

Centers for Medicare & Medicaid Services  

• The Centers for Medicare and Medicaid Services (CMS) latest news alerts. (Updated 8/14/20)
• For the latest COVID-19 related CMS guidance and FAQs visit the CMS Current Emergencies webpage. (Updated 8/14/20)
• CMS announced an Initiative to Transform Rural Health. (8/11/20) (New)

Food and Drug Administration   

• The Food and Drug Administration (FDA) provides a daily roundup on COVID-19 related actions. (Updated 8/14/20)
  • FDA updated its FAQs on Testing for SARS-CoV-2 relating to the development and performance of tests for SARS-CoV-2. (Updated 8/14/20)
  • FDA maintains its COVID-19 FAQs for the general public. (Updated 8/13/20)
  • FDA webpage for health professionals. (Updated 8/11/20)
  • The agency also maintains a public database of drug shortages. (Updated 8/12/20)
• FDA released its list of COVID-19 related medical devices in short supply. (8/14/20) (New)
• FDA updated its information on hand sanitizer products that consumers should not use. (Updated 8/14/20)
• The FDA posted new FAQs on importing medical devices during the COVID-19 pandemic. (8/11/20) (New)
• The FDA posted new FAQs on registration and listing of medical devices during the COVID-19 pandemic. (8/11/20) (New)
• The FDA cleared for marketing in the United States a surgical gown and three polymer patient examination gloves (K201530, K201531, K193666). (8/4/20) (New)
• FDA revoked EUA for Autobio Diagnostics Co., Ltd.'s, Anti-SARS-CoV-2 Rapid Test. (8/6/20) (New)
• FDA issued a warning letter for fraudulent COVID-19 products to:
• Oxford Medical Instruments USA, Inc. (8/12/20) (New)
• Soluciones Cosmeticas, SA de CV (8/11/20) (New)
• FDA issued emergency use authorization (EUAs) for: (New)
• LumiraDx UK Ltd., for it molecular test LumiraDx SARS-CoV-2 RNA STAR
• Biomeme, Inc., for its molecular test Biomeme SARS-CoV-2 Real-Time RT-PCR Test
• Solaris Diagnostics, for its molecular test Solaris Multiplex SARS-CoV-2 Assay
• Alpha Genomix Laboratories, for its molecular Alpha Genomix TaqPath SARS-CoV-2 Combo Assay
• George Washington University, for GWU SARS-CoV-2 RT-PCR test
• Yale University School of Public Health, for SalivaDirect COVID-19 test

 Other Federal Agencies   

• The Cybersecurity and Infrastructure Security Agency (CISA) announced tracking of an unknown malicious cyber actor who is spoofing the SBA COVID-19 loan relief webpage via phishing emails. (8/11/20) (New)
• The Export-Import Bank of the United States (EXIM) Board of Director notified Congress of two potential transactions that would utilize EXIM COVID-19 economic recovery measures. (8/11/20) (New)
• The Department of Housing and Urban Development (HUD) announced new flexibilities states and local governments can use in order to utilize Community Development Block Grant funds appropriated by the CARES Act. (8/14/20) (New)
• HUD awards $472 million to public housing authorities through the CARES Act funding to help low income families. (8/10/20) (New)
• The Internal Revenue Service (IRS) announced new steps to ensure people with children receive $500 Economic Impact Payments. (8/14/20) (New)
• The IRS released security tips for tax professionals to avoid phishing scams. (8/11/20) (New)
• What do you need to know as some of the first CARES Act instituted loan accommodations begin to expire? The A&B Financial Services & Products Group analyzes the latest guidance from federal banking regulators to aid financial institutions that seek to continue to accommodate borrowers still reeling from the pandemic. (8/4/20) (New)
• The Department of Labor and North American Meat Institute announced an alliance to protect meatpacking workers during the pandemic. (8/13/20) (New)
• The DOL’s Wage and Hour Division announced that McDonald’s franchisee pays back wages to employee denied paid sick leave to care for child after coronavirus closed childcare facility. (8/14/20) (New)
• The DOL announced guidance for the Lost Wages Assistance Program to provide claimants in most Unemployment Insurance programs up to $400 per week additional benefits starting on or after August 1, 2020 and ending December 27, 2020 at the latest. The funds are provided to a grant from the Federal Emergency Management Administration (FEMA). (8/12/20) (New)
• A federal judge ruled that restrictions in a DOL rule on which workers can access a temporary federal paid leave program are illegal and must be removed from the rule. (8/3/20)
• To understand the impact, A&B’S Labor and Employment Group examines how the court struck down four regulations for the Families First Coronavirus Response Act (FFCRA) and how the DOL might respond. (8/4/20) (New)
• The Small Business Administration (SBA) announced new reduced 504 loan debenture rates. (8/13/20) (New)
• The SBA released Interim Final Rule - Appeals of SBA PPP Loan Review Decisions (8/11/20) (New)
• Added questions 50 & 51 to the PPP FAQs (8/11/20) (New)
• FAQs for PPP Loan Forgiveness (8/11/20) (New)

For background and the most up-to-date information, please visit the Centers for Disease Control and Prevention Coronavirus Disease 2019 website: HERE. The additional federal agency links are provided by the White House Coronavirus Task Force:   What You Should Know:

• How to Protect Yourself & Others
• What to Do If You Are Sick with COVID-19
• Symptoms
• Facts about COVID-19
• Guidance Documents

Information for Businesses:

• Information for Communities, Schools, and Businesses
• Workplaces during the COVID-19 Pandemic
• Cleaning and Disinfecting Your Facility
• Worker Safety and Support
• COVID-19 Critical Infrastructure Sector Response Planning
• General Business Frequently Asked Questions
• Information for Small Businesses
• SBA: COVID-19 Resources
• Treasury: Assistance for Small Businesses
• DOL: Guidance for Preparing Workplaces for Coronavirus
• DOL: COVID-19 and the American Workplace
• DOL: OHSA Resources for Workers and Employers on COVID-19
• WHO: Get Your Workplace Ready for COVID-19
• CISA: Risk Management for COVID-19
• CISA: Telework Guidance and Resources
• CISA: Guidance on the Essential Critical Infrastructure Workforce

Information for Travel and Transportation:

• Information for Travel
• Travel in the United States
• Public Health Considerations for Reopening Mass Transit During the Covid-19 Pandemic
• COVID-19 Travel Recommendations by Country
• Travel Restrictions to Prevent the Spread of Disease
• Airline Guidance
• Cargo Ship Guidance
• Maritime Resources
• Returning from International Travel
• Travelers Returning from Cruise Ship and River Cruise Voyages
• Travel: Frequently Asked Questions and Answers
• Travelers Prohibited from Entry to the United States
• Communication Resources for Travelers
• State: Travel Advisories
• State: Traveler’s Checklist
• State: Smart Traveler Enrollment Program
• DOT: FAQs from FTA Grantees Regarding COVID-19
• DOT: Expanded Emergency Declaration
• FAA: Guidance for Air Carriers and Crews

Alston & Bird Coronavirus Links

• Alston & Bird Coronavirus Response & Relief Web page
• To Subscribe to Alston & Bird Advisories
• For Alston & Bird COVID-19 Insights and Events
• Previous Alston & Bird Coronavirus Advisories (not included in the above)
• July 15
  • Labor & Employment Advisory: DHS Reverses Course - International Students Allowed to Continue Studies and Employment in the U.S.
• July 9
  • “COVID-19 Will Have Lasting Impact on Construction Contracts,” Law360
• July 6
  • Finance Advisory: COVID-19 Update - What Your Business Needs to Know About the Corporate Governance and Insolvency Act of 2020
• July 2
  • Environment, Land Use & Natural Resources Advisory: EPA Modifies Guidance for Compliance During the COVID-19 Pandemic
• July 1
  • “What COVID-19 Means for the Future of Health Mergers,” Law360
• June 30
  • Securities Law Advisory: When In Doubt, SEC Wants You to Consider COVID-19 Disclosures
• June 15
  • International Tax Advisory: Who Says You Can’t Go Home? IRS Sends Care Package to Those Away From Home Due to COVID-19
• June 8
  • Into the Unknown: Employee Retention Credits Remain Murky
• June 5
  • Environmental, Land Use & Natural Resources Advisory: President Issues Executive Order on Expediting Infrastructure Investments
  • What’s in Store: A&B Review of the Challenges for Retailers During COVID-19
• June 3
  • Grand Reopening: Guidelines for Resuming Business Operations in California Amid COVID-19
• June 1
  • Federal Tax Advisory: Disaster Losses
• May 29
  • Environment, Land Use & Natural Resources Advisory: Emergency Rule 9 Amendment Provides Deadlines for Statutes of Limitations
• May 22
  • A&B Environment and Land Use Briefing: COVID-19 Articles Included
• May 21
  • Prescribing Paid Sick Leave -- An Important Tool for Primary Care During the Pandemic: JAMA Health Forum
• May 18
  • International Tax Advisory: Proposed Treasury Regulations Clarify UBTI “Silo” Rule
  • Financial Services Litigation / Financial Services & Products Advisory: CFPB Reflects on the Impact of COVID-19 and Provides a Window into Future Enforcement
• May 15
  • A&B Investment Management Updates, including items reflecting the impact of the coronavirus pandemic.
• May 12
  • Finance Advisory: Ginnie Mae Extends PTAP/C19 Assistance to Multifamily MBS Program
  • A&B Guide to Telehealth Waivers and Regulatory Flexibilities
  • The Digital Download -- Alston & Bird’s Privacy & Data Security Newsletter
• May 8
  • Finance Advisory: ESG During the Coronavirus Crisis -- Should You Care?
  • Health Care / Privacy & Data Security Advisory: Expansive Interoperability and Data-Sharing Requirements Require Attention Despite Delays in Enforcement
  • Financial Restructuring & Reorganization Advisory: Delaware Courts Leery of Shareholder Obstruction
• May 6
  • Finance Advisory: Federal Reserve Revises Main Street Lending Program, Adds Third Option
• May 5
  • Finance Advisory: Brexit and Its Potential Impact on Cross-Border Litigation Throughout Europe
  • Investment Management Advisory: Update on Relief Under the CARES Act for Fund Managers
• May 4
  • Food, Drug & Device/FDA Advisory: Examining the Drug Supply Chain -- How the Public Health Emergency Impacts DSCSA
• April 30
  • College & Universities Advisory: Schools Face Class Action as Parents and Students Sue for Refunds
  • White Collar Government & Internal Investigations Advisory: New PPP Funding Ups Ante for Compliance Failure--Audits on the Horizon
• April 29
  • Health Care / Health Care Litigation Advisory: COVID-19 A Tipping Point for Telehealth Expansion
• April 28
  • Labor & Employment Advisory: The New Executive Order Suspends Entry of Immigrant Visa Applicants into the U.S. for 60 days
• April 24
  • Commercial Litigation Advisory: COVID-19 Impacts on Statutes of Limitations
• April 23
  • International Trade & Regulatory Advisory: FEMA Issues Guidance on Exemptions for Critical PPE Export Restrictions
• April 22
  • Labor & Employment Advisory: Developing a Plan to Bring Your Employees Back to Work
• April 21
  • Financial Advisory: Forbearance Agreements in the age of COVID-19 and National Shelter-in-Place Orders
  • Antitrust / Mergers & Acquisitions / International Trade & Regulatory Advisory: COVID-19 Affect European Foreign Direct Investment Reviews: New EU Guidance Potentially Heralds Increased Protectionism
• April 20
  • Financial Advisory: FHFA Limits Servicer Advancing Obligations for Loans in COVID-19 Forbearance
• April 17
  • “INSIGHT: Businesses Better Brace for Post-Coronavirus Lawsuits” Bloomberg Law
  • Antitrust / Labor & Employment Advisory: Federal Antitrust Agencies Remind Businesses That Colluding on Labor Issues Remains Illegal During Pandemic
  • Labor & Employment / Health Care / Corporate & Finance Advisory: Ramping Up: What Does Restarting Look Like?
• April 16
  • International Tax Advisory: Risky Business - Allocating Losses When Your Supply Chain Is Disrupted
  • Finance Advisory: Ginnie Mae Expands Pass-Through Assistance Program to Finance Servicing Advances in Response to COVID-19
• April 15
  • “Force Majeure Clauses in the Face of COVID-19: Commercial Leasing Guidance (CA),” Lexis Practice Advisor
  • Federal Tax Advisory: IRS Issues COVID-19 Forbearance Guidance for REMICs and Investment Trusts
• April 14
  • Investment Advisory: Federal Reserve Announces Main Street Lending Program to Provide Liquidity to Small & Mid-Size Businesses
  • Investment Management Advisory: Relief Under the CARES Act for Fund Managers
• April 13
  • “As Pandemic Triggers Continuity Plans, What RIAs and BDs Should Ask Themselves,” Financial Planning
  • FDA & Environment Advisory: Cleaning Up After COVID-19? What You Need to Know Before You Manufacture, Import, or Sell Sterilizers, Sanitizers, Purifiers, and Disinfectants
  • Securities Law Advisory: SEC Reminds Companies to Keep Their Disclosures Looking Forward
• April 10
  • Securities Law Advisory: ISS Offers COVID-19-Conscious Policy Guidance
• April 9
  • Federal Tax Advisory: IRS Provides Partnerships a Mechanism to Claim Benefit of Retroactive CARES Act Provisions
  • Financial Services Advisory: Agencies Update Their Interagency Statement on Reporting Loan Modifications
  • Early Securities Class Actions Highlight COVID-19 Litigation Risk (Law360)
  • FDA Compliance & Enforcement Advisory: FDA Issues New Guidance on Supply-Chain Disruption Notifications During COVID-19 Emergency
  • Financial Restructuring & Reorganization Advisory: Protecting Recoveries in a Pandemic: What Creditors Can Do Right Now
• April 7
  • Updated FAQs Regarding Paid Leave Obligations Under the Families First Coronavirus Response Act
  • Cyber Alert: Cybersecurity and COVID-19: Four Categories of Cyber Threats and Practical Tips in Response
• April 6
  • Antirust Advisory: Production and R&D Joint Ventures in a Pandemic: Reducing Antitrust Risk
  • Financial Services Advisory: Regulatory Agencies Issue Mortgage Servicing Guidance and FAQs for the CARES Act
  • White Collar, Government Investigations Advisory: CARES Act Follows Familiar Blueprint for Oversight and Enforcement
• April 3
  • EU State Aid Measures in the Fight Against COVID-19 Pandemic
• April 2
  • USPTO Announces Additional Limited Extensions Due to the COVID-19 Pandemic
  • Deadline for Reg BI and Form CRS Compliance Remains on Track
  • What Does the Coronavirus Mean for Companies and Their Critical Offshore Services?
• April 1
  • Federal Tax Advisory: Downward Stock Attribution for CFC Purposes
  • Hospital EMTALA Obligations Under Recent COVID-19 Waivers
  • CMS Issues Blanket Waivers from Physician Self-Referral Law Sanctions
• March 31
  • Additional Families First Coronavirus Response Act Paid Leave FAQs for Employers
  • SEC Extends Timeframe for Regulatory Relief for Investment Advisers and Investment Companies
  • Responsibility for Construction Site Safety in a Coronavirus World
• March 30
  • Keep Mystery to a Minimum in Your SEC COVID-19 Disclosures
  • How the CARES Act Will Affect Banking During the Coronavirus Emergency
  • Economy in Chaos: Is Bankruptcy Inevitable for My Business?
  • CMS Announces Expansion of Medicare’s Accelerated and Advance Payment Program
• March 27
  • Utilization of Electronic Signatures and Records: What You Need to Know
  • SEC Extends Conditional Filing Relief to Companies Affected by COVID-19
  • COVID-19: What It May Mean for Landlords and Lenders Under Their CRE Facility Agreements
  • Congress Further Expands Medicare Telehealth Benefits with the CARES Act
• March 26
  • USTR to Consider Additional Tariff Exclusions Due to COVID-19 Pandemic
  • COVID-19 and Price Gouging
  • SEC Continues to Keenly Monitor Insider Trading During COVID-19 Pandemic
• March 25
  • Is the COVID-19 Outbreak an “Act of God”? Why It May Matter for Your Contracts
  • FDA and USDA Food Safety Response to COVID-19 & DHS “Critical Infrastructure” Classification of Food and Agriculture Sector
  • Does Your Force Majeure Provision Extend to the Coronavirus?
  • Competition Authorities Across Europe Relax Competition Law Enforcement During COVID-19 Outbreak
  • COVID-19 Impacts Antitrust Deal Reviews: New Procedures and Delays
• March 24
  • Health Care Providers with Exposure to COVID-19: What You Need to Know
  • Regulators Further Clarify Guidance Regarding Loan Modifications and Reporting
  • Avoiding Antitrust Risk as Industries Respond to the Coronavirus: Businesses Look to Collaborate & Federal Government Offers Expedited Avenues
• March 23
  • FDA Continues to Accelerate Availability of COVID-19 Tests
  • CFTC Issues No-Action Letter Offering Regulatory Relief for CPOs
  • Building a Case for Force Majeure in Construction Contracts
• March 20
  • Employee Benefits & Executive Compensation Advisory: Coronavirus Impact on Health Benefits: A Deeper Dive
  • FDA Compliance & Enforcement Advisory: FDA Temporarily Postpones Routine Domestic Inspections
• March 19
  • Antitrust / Mergers & Acquisitions Advisory: COVID-19 Impacts Antitrust Deal Reviews: New Procedures and Delays
  • Construction Advisory: Five Best Practices for Construction Industry Stakeholders During the Coronavirus Pandemic
  • Labor & Employment Advisory: Employee Leave Requirements Under the Families First Coronavirus Response Act
  • Labor & Employment / Health Care Advisory: Coronavirus (COVID-19) FAQs for Employers
• March 18
  • Cyber Alert: Six Practical Tips for Practicing Cyberhygiene in the Middle of a Global Pandemic
  • Advisory: Are You an “Essential Business” in California Counties Where Shelter-in-Place Order Have Been Issued?
• March 17
  • Finance Advisory: Coronavirus and Securitization: Disclosure and Diligence Issues
• March 16
  • Securities Law Advisory: SEC Provides Guidance on the Possible Impacts of COVID-19 on Annual Meetings
  • Health Care / Cybersecurity Preparedness & Response Advisory: COVID-19 and HIPAA: Privacy, Security, and Breach Response During a Global Pandemic
• March 13
  • Financial Services & Products Advisory: FINRA Guidance: COVID-19 and Business Continuity Planning
  • Food, Drug & Device/FDA Advisory: FDA Seeks Help to Solve Personal Protective Equipment Shortages
  • Securities Litigation Advisory: Securities Litigation Risk Arising Out of the Coronavirus Pandemic
• March 12
  • FDA Compliance & Enforcement Advisory: FDA Postpones Foreign Inspections Through April 2020: Considerations for Industry
• March 10
  • Labor & Employment / Health Care Advisory: Coronavirus, Employers, and Domestic Travel: A Complicated Business Decision
• March 6
  • Securities Law Advisory: SEC Provides Conditional Relief to Companies Affected by COVID-19
• March 5
  • Health Care Advisory: Congress Expands Medicare Telehealth Benefit Amid Coronavirus Concerns
• February 28
  • Labor & Employment / Health Care Advisory: The Coronavirus: Employer and Workplace Considerations